Zeus advises Arcis on funding deal

MANCHESTER-based corporate financer Zeus Capital has advised Arcis Biotechnology on a fundraising deal which has seen it secure fresh capital from a network of private investors.

Arcis, which produces a suite of environmentally-benign cleaning and germ-killing products for a diverse range of markets and applications, is already in discussions with several global companies who are keen to utilise its proprietary technology. The company is based at Colwyn Bay in North Wales.

Richard Hughes, director at Zeus Capital, said: “When Arcis approached us with their Bi-giene product, we saw it as a really exciting opportunity for ourselves and our network of private investors.

“Bi-giene is going to revolutionise the sector: as well as using green chemistry, it is very long-lasting and extremely efficacious. Bi-giene could soon become the leading brand in the anti-microbial market, and Arcis has the potential to be a leading North West business.”

Leigh Bradley, managing director at Arcis Biotechnology added: “I am delighted that Zeus Capital were able to not only secure funding for Arcis but also assist us in the development of our leadership team and industry contact network.

“Zeus has a wealth of invaluable experience and contacts in this sector, which will help us break through into a number of very exciting markets for our products.”